JP2012530683A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530683A5
JP2012530683A5 JP2011553179A JP2011553179A JP2012530683A5 JP 2012530683 A5 JP2012530683 A5 JP 2012530683A5 JP 2011553179 A JP2011553179 A JP 2011553179A JP 2011553179 A JP2011553179 A JP 2011553179A JP 2012530683 A5 JP2012530683 A5 JP 2012530683A5
Authority
JP
Japan
Prior art keywords
skin
moisture permeability
function
agent according
improving agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011553179A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530683A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011553179A priority Critical patent/JP2012530683A/ja
Priority claimed from PCT/JP2010/060796 external-priority patent/WO2010147238A1/en
Publication of JP2012530683A publication Critical patent/JP2012530683A/ja
Publication of JP2012530683A5 publication Critical patent/JP2012530683A5/ja
Pending legal-status Critical Current

Links

JP2011553179A 2009-06-19 2010-06-18 皮膚水分透過機能異常の予防又は治療剤 Pending JP2012530683A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011553179A JP2012530683A (ja) 2009-06-19 2010-06-18 皮膚水分透過機能異常の予防又は治療剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2009146051 2009-06-19
JP2009146051 2009-06-19
PCT/JP2010/060796 WO2010147238A1 (en) 2009-06-19 2010-06-18 Agent for preventing or treating abnormality in skin water permeation function
JP2011553179A JP2012530683A (ja) 2009-06-19 2010-06-18 皮膚水分透過機能異常の予防又は治療剤

Publications (2)

Publication Number Publication Date
JP2012530683A JP2012530683A (ja) 2012-12-06
JP2012530683A5 true JP2012530683A5 (enExample) 2013-08-01

Family

ID=42752972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011553179A Pending JP2012530683A (ja) 2009-06-19 2010-06-18 皮膚水分透過機能異常の予防又は治療剤

Country Status (5)

Country Link
EP (1) EP2442785A1 (enExample)
JP (1) JP2012530683A (enExample)
KR (1) KR20120032009A (enExample)
CN (1) CN102458351B (enExample)
WO (1) WO2010147238A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2823807B1 (en) * 2012-03-05 2021-03-17 Otsuka Pharmaceutical Co., Ltd. Sunscreen composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2844103B2 (ja) * 1990-02-09 1999-01-06 株式会社コーセー 皮膚外用剤
JP3413220B2 (ja) * 1992-08-17 2003-06-03 株式会社コーセー 肌荒れ改善剤
JP3172599B2 (ja) * 1992-10-16 2001-06-04 株式会社コーセー 細胞賦活剤
JP3578858B2 (ja) * 1995-12-11 2004-10-20 株式会社ノエビア 皮膚外用剤
JPH1129457A (ja) * 1997-07-04 1999-02-02 Kanebo Ltd 皮膚化粧料
WO1999055302A1 (en) * 1998-04-27 1999-11-04 Color Access, Inc. Composition and method for treatment of aging skin
JP4164683B2 (ja) * 2000-11-22 2008-10-15 大塚製薬株式会社 O/w型乳化組成物及びその調製方法
JP2003206224A (ja) * 2002-01-08 2003-07-22 Otsuka Pharmaceut Co Ltd 外用組成物
JP4627988B2 (ja) * 2002-04-09 2011-02-09 大塚製薬株式会社 細胞増殖用組成物
JP4084726B2 (ja) * 2003-09-30 2008-04-30 丸善製薬株式会社 コラーゲン合成促進剤、線維芽細胞増殖促進剤、サイクリックampホスホジエステラーゼ阻害剤、チロシナーゼ阻害剤、及び血小板凝集抑制剤、並びに化粧料及び飲食品。
JP2006225271A (ja) * 2005-02-15 2006-08-31 Otsuka Pharmaceut Co Ltd シワの予防又は改善剤
JP4980634B2 (ja) 2006-03-17 2012-07-18 ポーラ化成工業株式会社 肌荒れの予防、改善に好適な皮膚外用剤
EP2174647B1 (en) * 2007-08-06 2017-12-13 Otsuka Pharmaceutical Co., Ltd. Gel composition for external application containing an adenine compound
EP2238971B1 (en) * 2008-01-11 2017-09-27 Otsuka Pharmaceutical Co., Ltd. Composition for external application

Similar Documents

Publication Publication Date Title
HK1206362A1 (zh) 硫代氨基磷酸酯核苷酸前藥的固體形式
NO20073719L (no) Kjemiske forbindelser
JP2008184431A5 (enExample)
WO2009098715A3 (en) Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
EA201001821A1 (ru) Производные триазола, полезные для лечения заболеваний
WO2015042078A3 (en) Substituted aminopyrimidine compounds and methods of use
EA201291310A1 (ru) Композиция ингибитора jak для местного применения
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
CY1116315T1 (el) Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3
HK1213018A1 (zh) 橋接雙環核苷
WO2011143360A8 (en) Compositions, methods and systems for the synthesis and use of imaging agents
FR2982159B1 (fr) Composition cosmetique solide sous forme de poudre compacte
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
HK1202809A1 (en) Mammalian fetal pulmonary cells and therapeutic use of same
TR201904514T4 (tr) Makrosiklik LRRK2 kinaz inhibitörleri.
JP2009108025A5 (enExample)
NO20064659L (no) Nye kvarterniserte quinuklidin-estere
MX2011008074A (es) Macrolido anti-inflamatorio.
WO2010080754A3 (en) Nanoparticle pharmaceutical formulations
JP2013523758A5 (enExample)
MX2012013607A (es) Polisacarido de las semillas de tamarindo para usarse en el tatamiento de enfermedades inflamatorias.
WO2012051495A3 (en) Compositions and methods for enhancing the biological response to chemical agents and physical stimuli
CL2013000021A1 (es) Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable.
WO2012076280A3 (de) Wirkstoffkombination und haarbehandlungsmittel
JP2012097036A5 (enExample)